HUMA vs. SCHD
HUMA (Humacyte, Inc.) is a stock, while SCHD (Schwab U.S. Dividend Equity ETF) is Dividend fund tracking the Dow Jones U.S. Dividend 100 Index. Over the past 3 years, HUMA returned -41.18%/yr vs 14.19%/yr for SCHD. Their 0.22 correlation means their historical movements had little consistent relationship.
Performance
HUMA vs. SCHD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HUMA achieves a -31.97% return, which is significantly lower than SCHD's 24.03% return.
HUMA
- 1D
- -2.71%
- 1M
- -7.97%
- 6M
- -34.51%
- YTD
- -31.97%
- 1Y
- -71.34%
- 3Y*
- -41.18%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -42.74%
SCHD
- 1D
- 0.18%
- 1M
- 3.33%
- 6M
- 14.09%
- YTD
- 24.03%
- 1Y
- 31.54%
- 3Y*
- 14.19%
- 5Y*
- 9.54%
- 10Y*
- 12.76%
- ALL TIME*
- 13.39%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
HUMA Humacyte, Inc. | $2.80M | $4.45M | $9.32M |
| $786.88M | $715.86M | $685.58M |
HUMA vs. SCHD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
HUMA Humacyte, Inc. | -31.97% | -80.98% | 77.82% | 34.60% | -70.90% | -28.92% |
SCHD Schwab U.S. Dividend Equity ETF | 24.03% | 4.34% | 11.66% | 4.54% | -3.26% | 5.98% |
Correlation
The correlation between HUMA and SCHD is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.09 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (All Time) Calculated using the full available price history since Aug 26, 2021 | 0.22 |
The correlation between HUMA and SCHD shifts across timeframes, from 0.09 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HUMA vs. SCHD — Risk / Return Rank
HUMA
SCHD
HUMA vs. SCHD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Humacyte, Inc. (HUMA) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HUMA | SCHD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.45 | ||
| Sortino ratioReturn per unit of downside risk | -5.14 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.51 | -0.60 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 6.74 | -7.69 |
| Martin ratioReturn relative to average drawdown | -1.34 | 17.01 | -18.35 |
Loading charts...
Drawdowns
HUMA vs. SCHD - Drawdown Comparison
The maximum HUMA drawdown since its inception was -96.62%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for HUMA and SCHD.
Loading charts...
Drawdown Indicators
| HUMA | SCHD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.62% | -33.37% | -63.25% |
Max Drawdown (1Y)Largest decline over 1 year | -76.83% | -4.61% | -72.22% |
Max Drawdown (3Y)Largest decline over 3 years | -93.93% | -16.13% | -77.80% |
Max Drawdown (5Y)Largest decline over 5 years | — | -16.85% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.37% | — |
Current DrawdownCurrent decline from peak | -96.15% | -1.24% | -94.91% |
Average DrawdownAverage peak-to-trough decline | -76.82% | -3.30% | -73.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.37% | 1.82% | +52.55% |
Volatility
HUMA vs. SCHD - Volatility Comparison
Humacyte, Inc. (HUMA) has a higher volatility of 19.56% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 4.11%. This indicates that HUMA's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HUMA | SCHD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.56% | 4.11% | +15.45% |
Volatility (6M)Calculated over the trailing 6-month period | 86.67% | 8.11% | +78.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 114.24% | 11.13% | +103.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.22% | 14.39% | +83.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 98.22% | 16.72% | +81.50% |
Dividends
HUMA vs. SCHD - Dividend Comparison
HUMA has not paid dividends to shareholders, while SCHD's dividend yield for the trailing twelve months is around 3.13%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HUMA Humacyte, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHD Schwab U.S. Dividend Equity ETF | 3.13% | 3.82% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% |
Frequently Asked Questions
HUMA and SCHD have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HUMA has higher volatility (19.56%) compared to SCHD (4.11%). In terms of maximum drawdown, HUMA dropped -96.62% vs SCHD's -33.37%.
SCHD currently has the higher Sharpe Ratio (2.81 vs -0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HUMA and SCHD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer